My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}
AlphaStreet

Want to join the conversation?


$NI {{ '2015-08-03T14:37:56+0000' | timeago}} • Webcast

$NI 2Q15 Q&A: Ridzon of KeyBanc Capital Markets asked about Indiana rate case and strategy there with regards to rate days. Joseph answered that company is working out the details of that filing. The key element is to reposition the modernization efforts allowing for the deferral of the tedious investments made in 2014 and 2015.

User Robert Smith {{ '2017-04-26T21:13:12+0000' | timeago}}

$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.

User Leroy John {{ '2017-04-26T21:11:32+0000' | timeago}}

$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.

User Irene Grennan {{ '2017-04-26T21:08:01+0000' | timeago}}

Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.

User Barbara Salley {{ '2017-04-26T17:50:03+0000' | timeago}}

Back with a bang! $TWTR

User Amelita Yates {{ '2017-04-26T17:23:10+0000' | timeago}}

Even though $TMUS is behind $VZ and $T, it is playing catchup in style! 1.1 million new subscribers in Q1!!

$BSX {{ '2017-04-27T11:08:18+0000' | timeago}} • Announcement

$BSX's sales in 1Q17 rose to $2.16Bil, helped by revenue growth in all segments. In a YoY basis, MedSurg revenue jumped 15%; Cardiovascular grew 8%; and Rhythm Management increased 7%.

$BSX {{ '2017-04-27T11:01:45+0000' | timeago}} • Announcement

Medical device maker $BSX reported 10% growth in revenue in 1Q17, which helped it post higher earnings. Net earnings were $290MM or $0.21 per share, compared to $202 million or $0.15 per share a year ago. On an adjusted basis, net earnings grew to $0.29 per share.

$IRM {{ '2017-04-27T10:50:20+0000' | timeago}} • Announcement

$IRM still expects 2017 revenue growth of 8-10% on constant dollar basis, to $3.75-3.84Bil, adjusted EBITDA growth of 16-19% to $1.25-1.28Bil and adjusted FFO growth of 8-15% to $715-760MM. The company still predicts adjusted EPS of $1.15-1.25, which reflects a 8-18% growth year-over-year.

$IRM {{ '2017-04-27T10:50:05+0000' | timeago}} • Announcement

$IRM posted normalized funds from operations per share of $0.48, compared with $0.53 in the previous year quarter. FFO per share reflects a structural tax rate of 23.1% compared with a structural tax rate of 14% in 1Q16. The company reported adjusted FFO of $170.94MM during the quarter compared with $167.57MM in 1Q16.

$IRM {{ '2017-04-27T10:49:50+0000' | timeago}} • Announcement

$IRM reported a 7.4% decline in 1Q17 earnings due to higher interest expenses as well as a rise in depreciation and amortization expenses from Recall acquisition. Net income fell to $58.13MM or $0.22 per share from $62.77MM or $0.30 per share last year. Revenue grew 25.1% to $938.88MM. Adjusted EPS decreased to $0.24 from $0.33.